AARD EPS Estimates
Aardvark Therapeutics, Inc. Common Stock
$3.74
-$0.04(-1.06%)
28
Overall
60
Value
9
Tech
15
Quality
Market Cap
$82.72M
Volume
129.82K
52W Range
$3.35 - $16.60
Target Price
$11.11
AARD EPS estimates: the consensus estimate for Aardvark Therapeutics, Inc. Common Stock's current fiscal year is -$3.17 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
AARD EPS Estimates
- EPS estimate, current quarter
- $-0.74
- EPS estimate, next quarter
- $-0.73
- EPS estimate, current year
- $-3.17
- EPS estimate, next year
- $-2.52
- EPS growth, 3-year
- +0.00%
| Fiscal year | EPS |
|---|---|
| 2025 | $-2.93 |
| 2024 | $-5.15 |
| 2023 | $-1.82 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | AARD | $3.74 | -1.1% | 129.82K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Aardvark Therapeutics, Inc. Common Stock Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW